Picture of Genomtec SA logo

GMT Genomtec SA Cashflow Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Genomtec SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSPRESSARSARS
Standards:
PAS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.45-10.9-5.27-11.9-9.01
Depreciation
Non-Cash Items-1.229.04-0.0384.840.011
Other Non-Cash Items
Changes in Working Capital0.858-0.852-0.4923.05-0.106
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.69-2.5-5.48-3.6-7.95
Capital Expenditures-0.491-0.127-0.218-4.33-3.53
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.0180.0510-0.277
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.509-0.076-0.218-4.33-3.8
Financing Cash Flow Items1.21-0.018-0.022-0.191-0.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3.288.45-0.21810.711.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.085.87-5.922.770.042